Tan Nget Hong, Wong Kin Ying, Tan Choo Hock
Department of Molecular Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Department of Pharmacology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
J Proteomics. 2017 Mar 22;157:18-32. doi: 10.1016/j.jprot.2017.01.018. Epub 2017 Jan 31.
The venom proteome of Naja sputatrix (Javan spitting cobra) was elucidated through reverse-phase HPLC, nano-ESI-LCMS/MS and data mining. A total of 97 distinct protein forms belonging to 14 families were identified. The most abundant proteins are the three-finger toxins (3FTXs, 64.22%) and phospholipase A (PLA, 31.24%), followed by nerve growth factors (1.82%), snake venom metalloproteinase (1.33%) and several proteins of lower abundance (<1%) including a variety of venom enzymes. At subproteome, the 3FTx is dominated by cytotoxins (48.08%), while short neurotoxins (7.89%) predominate over the long neurotoxins (0.48%) among other neurotoxins of lesser toxicity (muscarinic toxin-like proteins, 5.51% and weak neurotoxins, 2.26%). The major SNTX, CTX and PLA toxins were isolated with intravenous median lethal doses determined as 0.13, 1.06 and 0.50μg/g in mice, respectively. SABU, the Indonesia manufactured homologous tri-specific antivenom could neutralize the CTX and PLA fraction with moderate potency (potency=0.14-0.16mg toxin per ml antivenom). The SNTX, however, was very poorly neutralized with a potency level of 0.034mg/ml, indicating SNTX as the main limiting factor in antivenom neutralization. The finding helps elucidate the inferior efficacy of SABU reported in neutralizing N. sputatrix venom, and supports the call for antivenom improvement.
The Javan spitting cobra, Naja sputatrix is by itself a unique species and should not be confused as the equatorial and the Indochinese spitting cobras. The distinction among the spitting cobras was however unclear prior to the revision of cobra systematics in the mid-90's, and results of some earlier studies are now questionable as to which species was implicated back then. The current study successfully profiled the venom proteome of authenticated N. sputatrix, and showed that the venom is made up of approximately 64% three-finger toxins (including neurotoxins and cytotoxins) and 31% phospholipases A by total venom proteins. The findings verified that the paralyzing components in the venom i.e. neurotoxins are predominantly the short-chain subtype (SNTX) far exceeding the long-chain subtype (LNTX) which is more abundant in the venoms of monocled cobra and Indian common cobra. The neurotoxicity of N. sputatrix venom is hence almost exclusively SNTX-driven, and effective neutralization of the SNTX is the key to early reversal of paralysis. Unfortunately, as shown through a toxin-specific assay, the immunological neutralization of the SNTX using the Indonesian antivenom (SABU) was extremely weak, implying that SABU has limited therapeutic efficacy in treating N. sputatrix envenomation clinically. From the practical standpoint, actions need to be taken at all levels from laboratory to production and policy making to ensure that the shortcoming is overcome.
通过反相高效液相色谱、纳升电喷雾电离液相色谱串联质谱法及数据挖掘,阐明了爪哇喷毒眼镜蛇(Naja sputatrix)的毒液蛋白质组。共鉴定出属于14个家族的97种不同蛋白质形式。最丰富的蛋白质是三指毒素(3FTXs,占64.22%)和磷脂酶A(PLA,占31.24%),其次是神经生长因子(1.82%)、蛇毒金属蛋白酶(1.33%)以及几种丰度较低(<1%)的蛋白质,包括多种毒液酶。在亚蛋白质组中,3FTx以细胞毒素为主(48.08%),而在毒性较低的其他神经毒素(毒蕈碱样毒素蛋白,占5.51%;弱神经毒素,占2.26%)中,短链神经毒素(7.89%)比长链神经毒素(0.48%)占优势。主要的短链神经毒素、细胞毒素和PLA毒素被分离出来,静脉注射对小鼠的半数致死剂量分别测定为0.13、1.06和0.50μg/g。印度尼西亚生产的同源三特异性抗蛇毒血清SABU能够以中等效力中和细胞毒素和PLA组分(效力=每毫升抗蛇毒血清0.14 - 0.16mg毒素)。然而,短链神经毒素的中和效果很差,效力水平为0.034mg/ml,表明短链神经毒素是抗蛇毒血清中和作用的主要限制因素。这一发现有助于阐明报道的SABU中和爪哇喷毒眼镜蛇毒液效果较差的原因,并支持改进抗蛇毒血清的呼吁。
爪哇喷毒眼镜蛇(Naja sputatrix)本身是一个独特的物种,不应与赤道喷毒眼镜蛇和中南半岛喷毒眼镜蛇混淆。然而,在90年代中期眼镜蛇系统分类修订之前,喷毒眼镜蛇之间的区别并不明确,一些早期研究的结果现在对于当时涉及的是哪个物种存在疑问。当前研究成功描绘了经鉴定的爪哇喷毒眼镜蛇的毒液蛋白质组,并表明毒液由约64%的三指毒素(包括神经毒素和细胞毒素)和31%的磷脂酶A组成(按毒液总蛋白计算)。这些发现证实,毒液中的麻痹成分即神经毒素主要是短链亚型(SNTX),远远超过在眼镜王蛇和印度眼镜蛇毒液中更丰富的长链亚型(LNTX)。因此,爪哇喷毒眼镜蛇毒液的神经毒性几乎完全由SNTX驱动,有效中和SNTX是早期逆转麻痹的关键。不幸的是,通过毒素特异性检测表明,使用印度尼西亚抗蛇毒血清(SABU)对SNTX的免疫中和作用极其微弱,这意味着SABU在临床上治疗爪哇喷毒眼镜蛇中毒时治疗效果有限。从实际角度来看,需要从实验室到生产以及政策制定的各个层面采取行动,以确保克服这一缺点。